Dermatologic toxicology in children

Pediatric Annals

Volumn 30, Issue 4, 2001, Pages 197-202

  Spray, A ^a   Siegfried, E ^a  

^a Department of Dermatology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DERIVATIVE; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIHISTAMINIC AGENT; CALCIPOTRIOL; CORTICOSTEROID; IODINE DERIVATIVE; ITRACONAZOLE; PRILOCAINE; SULFADIAZINE SILVER; TACROLIMUS;

CHILD; CHILDHOOD DISEASE; DERMATOLOGY; HUMAN; INFANT; INFANT DISEASE; PEDIATRICS; REVIEW; SKIN TOXICITY; TOXICOLOGY;

EID: 0035067648     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20010401-07     Document Type: Review

References (45)

1. Pharmacology and toxicology of infant skin
2. Hazards and potential hazards
3. Percutaneous drug absorption in the newborn: Hazards and uses
4. Dermatitis of the diaper region in infants (Jacquet dermatitis)
5. Cutaneous manifestations of acrodynia (pink disease)
6. Pentachlorophenol poisoning in a nursery for newborn infants: II. Epidemiologic and toxicology studies
7. Neurotoxicity of hexachlorophene in the human: I. A clinicopathologic study of 248 children
8. Boric acid poisoning
9. Comparison of stratum corneum thickness in children and adults
10. Neonatal skin and skin care
11. Methaemoglobinaemia in children treated with prilocainelignocaine cream
12. Petechial eruption after the application of EMLA cream
13. Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants
14. Iodine, thyroid function, and very low birth weight infants
15. Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants
16. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age
17. Silvadene toxicity
18. Agranulocytosis after application of silver sulfadiazine in a 2-month old infant
19. Leukopenia secondary to silver sulfadiazine: Frequency, characteristics, and clinical consequences
20. Topical diphenhydramine toxicity
21. Topically induced diphenhydramine toxicity
22. Diphenhydramine toxicity in a child with varicella: A case report
23. Central anticholinergic syndrome on therapeutic doses of cyproheptadine
24. Topical calcipotriol in childhood psoriasis
25. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis
26. Topical calcitriol in the treatment of chronic plaque psoriasis: A double-blind study
27. Hypercalcaemic crisis after excessive topical use of a vitamin D derivative
28. Guidelines of care for the use of topical glucocorticosteroids
29. An update on the therapeutic orphan
30. Topical glucocorticoids with improved risk-benefit ratio: Rationale of a new concept
31. Topical steroid holiday
32. Itraconazole oral solution for the treatment of onychomycosis
33. Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children
34. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children
35. Use of tacrolimus ointment in 3-6 year olds with atopic dermatitis
36. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients
37. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation
38. Successful treatment of infantile hemangiomas with interferon-alfa-2b
39. Successful interferon therapy in a neonate with life-threatening Kasabach-Merritt syndrome
40. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy
41. Interferons and cerebral palsy
42. Clinical pharmacokinetics in neonates
43. Transdermal drug delivery: Clinical aspects